Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational of GPI-anchored Protein-deficient (PNH-Type) Cells in Korean Patients With Bone Marrow Failure Syndrome and Having Hemolytic Paroxymal Nocturnal Hemoglobinuria (OPENK)

NCT03460301 is registered in ClinicalTrials.gov with Handok Inc. as lead sponsor.

NCT NCT03460301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03460301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational of GPI-anchored Protein-deficient (PNH-Type) Cells in Korean Patients With Bone Marrow Failure Syndrome and Having Hemolytic Paroxymal Nocturnal Hemoglobinuria (OPENK)
Lead sponsor
Handok Inc.
Phase
Observational
Overall status
Completed
Start date
March 24, 2015
Completion date
August 12, 2020
Enrollment
233 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pnh